Sponsor

University of Basel

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name University of Basel appears in 39 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials39
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

39 shown
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in SwitzerlandNCT03124212 · lead sponsor · 2017-04-01
RECRUITING
Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT TrialNCT06024291 · lead sponsor · 2023-09-15
COMPLETED
The DIALOGUE Study: Swiss-Korean Billateral CollaborationNCT04214210 · lead sponsor · 2022-04-15
COMPLETED
Hypertension and Retinal Microvascular DysfunctionNCT04763005 · lead sponsor · 2021-02-12
COMPLETED
High-intensity Interval Training in Heart Failure Patients With Preserved Ejection FractionNCT03184311 · lead sponsor · 2020-07-01
UNKNOWN
Sportcheck Follow-UpNCT03085498 · lead sponsor · 2017-11-01
COMPLETED
Mobile Exergaming in Type 2 DiabetesNCT02657018 · lead sponsor · 2016-08-01
COMPLETED
Exercise and Arterial Modulation in YouthNCT02853747 · lead sponsor · 2016-05-01
COMPLETED
Exercise, Arterial Cross-Talk Modulation and Inflammation in an Ageing PopulationNCT02796976 · lead sponsor · 2016-03-01
COMPLETED
Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral HemodynamicsNCT02596165 · lead sponsor · 2016-03-01
TERMINATED
Light, Exercise Intensity and Mood in OverweightNCT02636335 · lead sponsor · 2016-01-01
COMPLETED
E-Bike Versus Classic Bike Intervention TrialNCT02495740 · lead sponsor · 2012-05-01
COMPLETED
New Markers for Treatment Response to Radiotherapy in Prostate CancerNCT06159998 · lead sponsor · 2009-07-01
WITHDRAWN
REtinal Markers In Neuroinflammatory Diseases ("REMIND")NCT06369766 · collaborator · 2024-01-31
RECRUITING
Controlled Evaluation of an Exercise Program for Overweight AdolescentsNCT06923865 · collaborator · 2025-10-01
ENROLLING_BY_INVITATION
Supporting Patients Starting New Medicines: Evaluating the myCare Start Service in SwitzerlandNCT07036471 · collaborator · 2025-06-01
NOT_YET_RECRUITING
Development of Machine Learning Models for the Prediction of BMI and Complications After Bariatric Surgery (CABS-Study)NCT05710913 · collaborator · 2023-01-05
UNKNOWN
Tolerability of Lopinavir Versus Dolutegravir for Children and Adolescents Living With HIVNCT05426421 · collaborator · 2022-07-11
COMPLETED
DreaMS - Validation Study 1NCT05009160 · collaborator · 2022-03-30
ACTIVE_NOT_RECRUITING
COMPuter-assisted Self-training to Improve EXecutive FunctionNCT04229056 · collaborator · 2020-06-01
ACTIVE_NOT_RECRUITING
Genotype-Informed Versus Empiric Management of VirEmiaNCT04233242 · collaborator · 2020-03-03
COMPLETED
Dolutegravir in Real Life in LesothoNCT04238767 · collaborator · 2020-02-10
COMPLETED
Peer-Educator-coordinated vs Nurse-coordinated ART Refill for Adolescents and Young Adults Living With HIV in LesothoNCT03969030 · collaborator · 2019-11-01
COMPLETED
Neuregulin-1 in Patient With Different Forms of Cardiovascular Diseases: a Pilot StudyNCT04391491 · collaborator · 2019-03-01
COMPLETED
Village-based vs Clinic-based ART Care - a Cluster Randomized Controlled Trial in LesothoNCT03630549 · collaborator · 2018-08-16
COMPLETED
HOme-based SElf-testiNG - a Cluster Randomized Controlled Trial in Rural Lesotho (HOSENG)NCT03598686 · collaborator · 2018-07-26
COMPLETED
"Switch Either Near Suppression Or THOusand"NCT03088241 · collaborator · 2017-08-01
COMPLETED
Short Adherence Intervention for Viral Re-suppressionNCT03242980 · collaborator · 2017-05-18
COMPLETED
Same-day ART Initiation Versus Standard of Care After Positive HIV-test Result in Rural LesothoNCT02692027 · collaborator · 2016-02-01
COMPLETED
Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural LesothoNCT02126696 · collaborator · 2014-05-01
COMPLETED
Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With MetforminNCT02111967 · collaborator · 2014-03-01
COMPLETED
Intervention to Improve Inhalative AdherenceNCT02386722 · collaborator · 2014-01-01
COMPLETED
Immunogenicity and Safety of Vaccinations in Immunocompromised PersonsNCT01947465 · collaborator · 2013-10-01
COMPLETED
Development and Prevention of Severe Heart Disease in Systemic SclerosisNCT01829126 · collaborator · 2013-04-01
UNKNOWN
Development and Prevention of Pulmonary Hypertension in Systemic SclerosisNCT01840748 · collaborator · 2013-04-01
UNKNOWN
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer PatientsNCT01402089 · collaborator · 2012-01-01
COMPLETED
Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk StudyNCT00878813 · collaborator · 2009-03-01
COMPLETED
Effect of a Physical-activity-promoting Environment on Motor Skills, Physical Activity and Quality of Life of Children in Childcare SettingsNCT00967460 · collaborator · 2009-01-01
COMPLETED
Influence of a Lifestyle Intervention in Preschool Children on Physiological and Psychological ParametersNCT00674544 · collaborator · 2008-05-01
COMPLETED

Drugs studied in this sponsor's trials

5 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Basel as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
caffeine1
dolutegravir1
erlotinib1
midazolam1
sunitinib1
caffeine RxCUI 1886 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial dolutegravir RxCUI 1433868 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial erlotinib RxCUI 337525 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial midazolam RxCUI 6960 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial sunitinib RxCUI 357977 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator26
lead sponsor13
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.